ClinicalTrials.govpublic full text
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
cardiovascular diseases, dyslipidemias, statin adverse reaction, pharmacogenic myopathy, statin, statin associated muscle symptoms, cardiovascular disease, cost-effectiveness, phase iv clinical trial, pharmacogenetic, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807216
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.